Your browser doesn't support javascript.
loading
Beta-Glucans in the treatment and prevention of allergic diseases
Jesenak, Milos; Banovcin, Peter; Rennerova, Zuzana; Majtan, Juraj.
Afiliação
  • Jesenak, Milos; Comenius University in Bratislava. Jessenius Faculty of Medicine. Department of Paediatrics. Martin. Slovakia
  • Banovcin, Peter; Comenius University in Bratislava. Jessenius Faculty of Medicine. Department of Paediatrics. Martin. Slovakia
  • Rennerova, Zuzana; Pneumo-Alergo Centrum. Bratislava. Sñovakia
  • Majtan, Juraj; Slovak Medical University. Faculty of Medicine. Slovak Academy of Sciences. Bratislava. Slovakia
Allergol. immunopatol ; 42(2): 149-156, mar.-abr. 2014. ilus
Artigo em Inglês | IBECS | ID: ibc-121014
Biblioteca responsável: ES1.1
Localização: BNCS
β-glucans are a group of biologically active polysaccharides of natural origin with a proven pleiotropic immunomodulation effect. Their efficacy has been confirmed in the therapeutic treatment and prevention of various infectious diseases, secondary immune defects and also of oncologic disorders. Allergic diseases are one of the most frequent diseases and their prevalence continues to increase. They develop as a consequence of dysregulation of the immune system, especially when there is failure in the equilibrium of the response of TH1/TH2 lymphocytes towards TH2. New therapeutic approaches in the treatment of immunopathological conditions (e.g. allergic or oncologic) are directed to restoring the equilibrium among different T lymphocyte subpopulations. Based on in vitro experiments, and also on animal and human clinical studies, there is much evidence for the importance of β-glucans in the treatment and also prevention of allergic diseases; this opens new perspectives on the use of this widespread and popular group of natural substances
RESUMEN
No disponible
Assuntos
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Contexto em Saúde: Agenda de Saúde Sustentável para as Américas Problema de saúde: Objetivo 10: Doenças transmissíveis Base de dados: IBECS Assunto principal: Beta-Glucanas / Hipersensibilidade Tipo de estudo: Fatores de risco Limite: Humanos Idioma: Inglês Revista: Allergol. immunopatol Ano de publicação: 2014 Tipo de documento: Artigo Instituição/País de afiliação: Comenius University in Bratislava/Slovakia / Pneumo-Alergo Centrum/Sñovakia / Slovak Medical University/Slovakia
Buscar no Google
Coleções: Bases de dados nacionais / Espanha Contexto em Saúde: Agenda de Saúde Sustentável para as Américas Problema de saúde: Objetivo 10: Doenças transmissíveis Base de dados: IBECS Assunto principal: Beta-Glucanas / Hipersensibilidade Tipo de estudo: Fatores de risco Limite: Humanos Idioma: Inglês Revista: Allergol. immunopatol Ano de publicação: 2014 Tipo de documento: Artigo Instituição/País de afiliação: Comenius University in Bratislava/Slovakia / Pneumo-Alergo Centrum/Sñovakia / Slovak Medical University/Slovakia
...